Three Prescriptions, One Closed Prescriber
A community pharmacy in Chicago receives three problematic orders in one afternoon. (1) For a 2-year-old whose weight is not on the prescription: 'amoxicillin 250 mg/5 mL - 10 mL by mouth three times daily for 10 days; dispense 150 mL.' (2) For a 4-year-old with an upper respiratory infection: 'promethazine with codeine syrup - 5 mL every 6 hours as needed for cough; dispense 120 mL.' (3) An electronic prescription for alprazolam 0.5 mg, quantity 30, 'one tablet at bedtime,' two refills, with a 'do not fill before' date of next Tuesday, transmitted today. The prescriber's office is closed and the answering service will only take a message. The pharmacist knows each patient's family and wants to help.
1. Work through prescription (1): the dose math, the internal inconsistency, and exactly what the pharmacist may and may not adjust without the prescriber.
Read the worked answer
The math. 10 mL of 250 mg/5 mL = 500 mg per dose; three times daily = 1500 mg/day. A typical 2-year-old is roughly 12 kg, so this is about 125 mg/kg/day - well above the standard 45 mg/kg/day (and above even the 90 mg/kg/day high-dose regimen used for acute otitis media).
The internal inconsistency. 10 mL three times daily for 10 days requires 300 mL. The prescription says dispense 150 mL - a five-day supply with ten days of directions. Independent of the dose question, the order does not add up.
What she may do without the prescriber. Essentially nothing that changes the order. She may not reduce the dose to a 'reasonable' pediatric dose, may not shorten the duration, and may not dispense 300 mL because she thinks that's what was meant. Guessing at a pediatric dose is a prescribing act. If she cannot reach the prescriber, the defensible options are: hold the prescription, contact the child's other prescriber or an on-call covering practitioner, or - if the child's condition makes delay unsafe - direct the family to a setting where the child can be evaluated.
What she should document. The dose calculation she performed, the quantity discrepancy, the contact attempts and their times, and the advice given to the family. If she ultimately dispenses after reaching the prescriber, note the clarifying conversation and who authorized the corrected quantity.
Exam framing: an incomplete or internally inconsistent prescription is not a puzzle to be solved by the pharmacist; it is a prescription to be clarified. The pharmacist's expertise defines the question she asks the prescriber, not the answer she substitutes.
2. What should happen with prescription (2), and why is 'the prescriber wrote it' not the end of the analysis?
Read the worked answer
It should not be filled as written. Promethazine–codeine is a codeine-containing cough and cold product, and codeine is contraindicated for cough in children - the pediatric contraindication in this age group is well established in FDA labeling and professional guidance, and promethazine carries its own age-related contraindications and boxed warning about severe respiratory depression. A 4-year-old with a URI is precisely the population at risk. Much of the harm from these products has come from exactly this scenario: a routine URI, a syrup, and an unsupervised opioid exposure.
'The prescriber wrote it' answers the wrong question. Legality (a valid order exists) and appropriateness (the drug is safe for this patient) are different tests, and the pharmacist is the last checkpoint on both. Filling a contraindicated pediatric opioid preparation can be a dispensing error and a professional discipline matter even though a signature exists.
What to do: do not dispense; contact the prescriber and recommend a non-opioid alternative (analgesic/antipyretic, hydration, and reassurance are usually the actual therapy for a viral URI); educate the family about why the syrup isn't being provided and what to watch for; document the refusal, the recommendation, and the prescriber's response. If the prescriber is unreachable, the correct default is not to dispense.
Contrast with (1): in (1), the dose was wrong and fixable by clarification. Here the product itself is the problem for this patient.
3. Analyze prescription (3) - the 'do not fill before' date, the refills, and whether the pharmacist can act without reaching the prescriber.
Read the worked answer
The 'do not fill before' date is enforceable. A prescriber may direct that a prescription not be filled until a specified date, and the pharmacy must honor it. Filling before that date without the prescriber's authorization is filling without a valid order. On or after the date, the prescription may be filled.
The refills are permissible on their face. Alprazolam is Schedule IV; federal rules permit up to five refills within six months of the date of issue, so two refills is within limits. What matters is the date of issue versus the fill date: if the prescription is filled on the date specified, the six-month clock runs from issuance, and an unused refill expires six months after issuance regardless of when it was first filled. She may not add refills, extend the six-month window, or create a new prescription when the refills run out.
Does she need the prescriber today? For the fill itself - no, provided she waits for the specified date and everything else is in order (patient, prescriber, drug, directions, quantity, and no red flags). She should not call to 'get permission to fill early'; the answer is the calendar.
What she should check before that date: whether the prescription is otherwise valid (prescriber authority, patient identity, any duplicate therapy or interaction), whether the patient is filling elsewhere, and - for a benzodiazepine - whether counseling on sedation, driving, and interaction with opioids or alcohol has been done.
Documentation: note the date received, the date it may be filled, and the fact that it was held. If the patient insists on an early fill, she can contact the prescriber; absent authorization, the answer is no.